Drug Discovery and Development Researchers are vital professionals responsible for the early-stage identification and creation of new therapeutic drugs. Their work begins with understanding the biological basis of diseases, identifying potential drug targets, and screening chemical compounds or biologics that could modify disease processes. These researchers employ a wide range of techniques, including high-throughput screening, molecular modeling, and bioinformatics, to discover promising drug candidates. Their role is crucial in ensuring that novel compounds are not only effective but also safe for use in humans. The discovery process often involves collaboration across multiple disciplines, including chemistry, biology, and pharmacology.
Once promising drug candidates are identified, drug discovery and development researchers guide these compounds through the rigorous stages of preclinical and clinical testing. This includes optimizing drug formulations, determining appropriate dosages, and assessing pharmacokinetics and toxicity profiles. These researchers are responsible for advancing potential drugs from the laboratory to the clinic, ensuring compliance with regulatory standards and minimizing risks for patients. As the field of drug development evolves, these researchers are embracing new technologies such as artificial intelligence and precision medicine to streamline the process and create more targeted, effective therapies. Their work continues to push the boundaries of medical science, offering the potential to cure diseases and improve health outcomes on a global scale.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada